Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells

Oncology Letters

Volumn 6, Issue 4, 2013, Pages 875-877

  Tomizawa, Ayako ^a   Kanno, Syu Ichi ^a   Osanai, Yuu ^a   Yomogida, Shin ^a   Ishikawa, Masaaki ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Caffeic acid; Cytotoxicity; NALM 6; Telomerase; Telomerase reverse transcriptase

Indexed keywords

CAFFEIC ACID DERIVATIVE; CAFFEIC ACID UNDECYL ESTER; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DENSITOMETRY; DNA ISOLATION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SYNTHESIS; WESTERN BLOTTING;

EID: 84881574623     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1482     Document Type: Article

References (17)

1. Counter CM, Avilion AA, LeFeuvre CE, et al: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J11: 1921-1929, 1992.
2. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science266: 2011-2015, 1994.
3. Shay JW and Wright WE: Telomerase activity in human cancer. Curr Opin Oncol8: 66-71, 1996.
4. Colangelo D and Osella D: Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach? Curr Med Chem12: 3091-3102, 2005.
5. Schiffer CA: Treatment of high-grade lymphoid malignancies in adults. Semin Hematol38 (4 Suppl 10): 22-26, 2001.
6. Tomizawa A, Kanno S, Osanai Y, et al: Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 humanBcell leukemia cells. Oncol Rep29: 425-429, 2013.
7. Uwai K, Osanai Y, Imaizumi T, Kanno S, Takeshita M and Ishikawa M: Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages. Bioorg Med Chem16: 7795-7803, 2008.
8. Kanno S, Maeda N, Tomizawa A, Yomogida S, Katoh T and Ishikawa M: Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatinB towards susceptible NALM-6 human B cell leukemia cells. Int J Oncol40: 1391-1396, 2012.
9. Watanabe K, Kanno S, Tomizawa A, Yomogida S and IshikawaM: Acacetin induces apoptosis in human Tcell leukemia Jurkat cells via activation of a caspase cascade. Oncol Rep27: 204-209, 2012.
10. Kanno S, Higurashi A, Watanabe Y, Shouji A, Asou K and Ishikawa M: Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol Lett152: 149-158, 2004.
11. Greider CW: Telomerase activation. One step on the road to cancer? Trends Genet15: 109-112, 1999.
12. Martens UM, Brass V, Sedlacek L, et al: Telomere maintenance in human Blymphocytes. Br J Haematol119: 810-818, 2002.
13. Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A and Akyol O: The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci16: 2064-2068, 2012.
14. Braun T, Carvalho G, Fabre C, Grosjean J, Fenaux P and Kroemer G: Targeting NF-kappaB in hematologic malignancies. Cell Death Differ13: 748-758, 2006.
15. Yin L, Hubbard AK and Giardina C: NF-kappaB regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem275: 36671-36675, 2000.
16. Ghosh A, Saginc G, Leow SC, et al: Telomerase directly regulates NF-κB-dependent transcription. Nat Cell Biol14: 1270-1281, 2012.
17. Lobetti-Bodoni C, Bernocco E, Genuardi E, Boccadoro M and Ladetto M: Telomeres and telomerase in normal and malignant B-cells. Hematol Oncol28: 157-167, 2010.